Clinical Trial Update: Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a conditioning regimen of fludarabine phosphate, cyclophosphamide, and total body irradiation followed by donor stem cell transplant in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia Bcr-abl1 Positive
• Myelodysplastic Syndrome
• Myelofibrosis
• Non-hodgkin Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine phosphate (Fludarabine phosphate)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission | Phase 2 | Status: TERMINATED | Results posted: 2024-04-02